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Abstract
Background: Due to the constant use, misuse, and over-prescription of antibiotics, antibiotic
resistance has become a global public health threat. Methicillin-Resistant Staphylococcus aureus
(MRSA) continues to prevail in healthcare settings and is the cause of many nosocomial infections
worldwide. A risk factor for developing an active MRSA infection is the colonization of the
pathogen in the anterior nares. Over the past two decades, MRSA infections have increased in both
the hospital and the community setting, often infecting healthy individuals lacking common risk
factors. Healthcare workers with constant exposure to MRSA are more likely to be colonized and
can potentially serve as vectors in the transmission of MRSA to hospital patients. Objective: The
objective of this project is to establish the carrier status of first-year osteopathic medical students
by conducting nasal swabs on the participants and characterizing the bacteria through selective
media and genetic characterization methods. Methods: Researchers from Burrell College of
Osteopathic Medicine recruited first-year osteopathic medical students to serve as subject
participants and graduate students from New Mexico State University to serve as control
participants. BCOM researchers administered a participant survey and conducted nasal swabs on
all participants. The samples were then transported to UTEP for laboratory analysis where they
underwent identification for Staphylococcus aureus and MRSA. Results: 36 participants were
recruited, 32 subjects and 4 controls. 33.3% resulted in being positive for Staphylococcus aureus
colonization, 31.3% of subjects and 50% of controls. None of the samples resulted in being positive
for MRSA. Conclusions: The results of this thesis study are similar to those of other studies who
examined prevalence of colonization in pre-clinical medical students. In addition, the results are
similar to the CDC’s estimate of 33% of individuals being S. aureus carriers and 2% being MRSA
carriers. The findings of this study are relevant to U.S.-Mexico border region by examining the
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colonization prevalence in future healthcare professionals and continuing the surveillance to assess
the impact of healthcare exposure on nasal colonization.
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Chapter 1: Introduction
Despite advances in sanitation, disinfection, antimicrobials, and the introduction of new
antibiotics over the past few decades, Methicillin-Resistant Staphylococcus aureus (MRSA)
continues to prevail and burden patients, residents, and communities (Böcher, Gervelmeyer,
Monnet, Molbak, & Skov, 2008). Resistance to methicillin was reported in the United Kingdom
only two years after the introduction of methicillin in 1959, and resistance rapidly disseminated
across the globe, primarily in healthcare settings (Yano et al., 2009). Resistance to methicillin is
the result of an altered penicillin-binding protein, PBP2a, encoded by the mecA gene. Similar
strains have been isolated from healthcare settings around the world and continues to be the culprit
of many nosocomial infections worldwide (Cadena, Thinwa, Walter, & Frei, 2016; Dulon, Peters,
Schablon, & Nienhaus, 2014; Graffunder & Venezia, 2002; Muder, Brennen, & Goetz, 1993).
Risk factors associated with MRSA infection are similar but slightly different to risk factors
associated with MRSA colonization. Previous hospitalization, social deprivation score, surgery,
antibiotic use, and MRSA colonization itself were all found to increase the risk of developing an
active MRSA infection (Bagger, Zindrou, & Taylor, 2004; Böcher et al., 2008; Cadena et al., 2016;
Catry et al., 2014; Graffunder & Venezia, 2002; Gupta, MacIntyre, Vanasse, & Dembry, 2007;
Stenehjem & Rimland, 2013; Yano et al., 2009). Factors that increase the risk of becoming a
MRSA carrier include a history of MRSA carriage, being a nurse or having an ICU occupation,
having contact with MRSA carriers, home-care of relatives, having acne, having chronic
inflammatory bowel disease, contact with a domestic animal and with raw meat, and having an
acute illness (Sassmannshausen et al., 2016). Similar factors found to increase the risk of
developing an active MRSA infection and colonization in an individual’s nares was previous
hospitalization within the past year and the use of oral antibiotics (Böcher et al., 2008; Cadena et
al., 2016; Graffunder & Venezia, 2002; Hidron et al., 2005).
MRSA strains can colonize at different sites of the body, however it is commonly isolated
from the anterior nares. Individuals can be classified into four different statuses that identify their
1

carriage pattern: Non-carriers, persistent carriers, intermittent carriers and transient carriers (Dulon
et al., 2014; Kluytmans J, van Belkum A, & Verbrugh H, 1997). Healthcare workers are most
likely to be transiently colonized, colonization during their work shift and the loss of colonization
before the start of their next work shift, however, healthcare workers face a greater risk of
persistent colonization if they work in an area where there is constant exposure to MRSA (Dulon
et al., 2014). Healthcare workers who are colonized and in constant interaction with patients pose
a greater risk in transmitting the pathogen to vulnerable patients, such as infants and those who are
immunocompromised.
The constant transmission of MRSA in a healthcare setting has been termed HealthcareAssociated MRSA (HA-MRSA). Risk factors for contracting HA-MRSA were the risk factors
known to increase the chances of an individual contracting MRSA in general and consisted of
hospitalization, surgery, and dialysis (David & Daum, 2010; Huang et al., 2006). By the 1990’s
MRSA began burdening communities and infecting people who had no previous risk factors for
MRSA. As MRSA rapidly disseminated across communities, Community-Associated MRSA
(CA-MRSA) was investigated and was found to be clinically and genetically different than HAMRSA (Hsiao, Ong, Chuang, Ma, & Huang, 2015). CA-MRSA generally causes skin and soft
tissue infections, has greater susceptibility to antimicrobial agents, carry the PVL gene and have
different genetic elements than HA-MRSA (Hsiao et al., 2015). CA-MRSA drew attention by
infecting otherwise healthy individuals that lacked the common risk factors known for MRSA
infection, and by its increasing presence in healthcare settings (David & Daum, 2010).
Treatment of MRSA consists of the administration of oral and intravenous antibiotics,
however the specific antibiotic may differ between patients and whether the patient is infected with
a HA-MRSA strain or a CA-MRSA strain (PACOSM, 2017). When treating colonized individuals,
a decolonization method can be followed to eliminate MRSA that is colonized in the anterior nares.
Prevention is key to decreasing MRSA transmission both in a healthcare setting and among
community members. Handwashing with soap and water is recommended to avoid transmission
of MRSA through contact (Gilboy, 2011; Simor & Loeb, 2004). Healthcare professionals are
2

encouraged to use proper personal protective equipment and community members are encouraged
to maintain proper wound care and disinfect athletic equipment properly (Gilboy, 2011; Hessen,
2017).
The U.S.-Mexico border area is a region of interest when studying infectious diseases due
to the high mobility of residents crossing the border every single day, with more than 4 million
border crossings per month (Rivera et al., 2009). The border region has a larger percentage of
residents living in poverty, higher unemployment rates and higher fertility rates when compared
to the rest of the United States (Migration Policy Institute, 2006; Pan American Health
Organization, 2012). People in need of medical advice and medical prescriptions cross the border
to obtain services and medication at a much lower price (Homedes & Ugalde, 2012; Rivera et al.,
2009). Such practices result in increased antibiotic consumption, and antibiotic consumption has
been correlated with increasing antibiotic resistance (Homedes & Ugalde, 2012). United States
MRSA statistics demonstrate a slight decrease in the incidence of MRSA, however the
Standardized Infection Ratio (SIR) for hospitals located in El Paso, Texas were much higher than
the state SIR (Medicare, 2017).
This thesis study aims to determine the prevalence of MRSA colonization among first-year
osteopathic medical students at a medical school located at the southern U.S.-Mexico border
region. Due to the fact that medical students most likely have prior healthcare experience, it is
hypothesized the prevalence of MRSA colonization will be higher than the CDC estimate of 2%.

3

Chapter 2: Background and Significance
2.1 Methicillin-Resistant Staphylococcus aureus Infections (MRSA)
2.1.1 Overview
Staphylococcus aureus can often be found on different sites of the body while having little
to no pathogenicity effect on the host. S. aureus is most commonly found on the skin and, in some
people, can colonize asymptomatically in the nose (Hessen, 2017). Although S. aureus can be the
culprit of a variety of infections, it is usually easily treated and cured by taking oral antibiotics.
However, the constant use, misuse, and over-prescription of antibiotics has led to multiple S.
aureus strains acquiring resistance to a wide variety of antibiotics (Monecke et al., 2011).
Penicillin, which inhibits bacterial cell wall synthesis, was a groundbreaking discovery by
Alexander Fleming in 1928 that would eventually allow millions of people to be cured from simple
infections previously known to be life threatening (Kong, Schneper, & Mathee, 2010). By the
1940’s, penicillin was being offered to the public to treat patients with bacterial infections
(Monecke et al., 2011). Within the next decade, the public would experience the first wave of
antibiotic resistance, causing penicillin-resistant S. aureus to be a global pandemic (Chambers &
DeLeo, 2009). The discovery of resistant strains led to the development of the semi-synthetic
penicillin’s; methicillin, oaxicillin, and cephalosporins (Monecke et al., 2011). Just a year after the
introduction of these antibiotics, the United Kingdom reported their discovery of a strain resistant
to methicillin, which was later referred to as methicillin-resistant Staphylococcus aureus (MRSA)
(Monecke et al., 2011). The acquisition of the mecA gene, a genetic sequence that confers broadspectrum beta-lactam resistance to penicillins, cephalosporins and carbapenems, is responsible for
converting regular S. aureus to MRSA, also known as Oaxicillin-Resistant Staphylococcus aureus
(ORSA) (Chambers & DeLeo, 2009; Monecke et al., 2011).
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MRSA can exhibit resistance to multiple antibiotics through multiple mechanisms. The
original S. aureus mechanism of resistance to beta-lactam antibiotics was through the action of the
beta-lactamase enzyme, which hydrolyzes the beta-lactam ring (Fishovitz, Hermoso, chang, &
Mobasherry, 2014). When beta-lactamase containing organisms were introduced to methicillin,
they were susceptible to the antibiotic and effectively treated. When methicillin resistance arose,
it was soon discovered to be the result of a different resistance mechanism. Thus, the mechanism
of interest is through the action conferred by the mecA gene. Methicillin is effective by inhibiting
the activity of penicillin binding proteins (PBP). Penicillin binding proteins are members of a
group of enzymes known as transpepdidases. Transpepdisases are responsible for cross-linking the
peptidoglycan layer during bacterial cell wall synthesis. Therefore, when penicillin binds to
penicillin binding proteins, it inhibits bacterial cell wall synthesis resulting in a weak cell wall that
will eventually rupture (Fishovitz et al., 2014). The mecA gene encodes for a penicillin binding
protein (PBP) known as PBP2a. While methicillin has the ability to inhibit all other PBP’s, PBP2a
has a low affinity for methicillin and continues cross-linking the bacterial cell wall, rendering
penicillin to be ineffective (Fishovitz et al., 2014). The mecA gene is important because it has the
ability to be horizontally transferred to other strains, allowing for the widespread of resistance.
The mecA gene is encoded on a mobile genetic element known as the Staphylococcal Cassette
Chromosome mec (SCC mec) (Wielders, Fluit, Brisse, Verhoef, & Schmitz, 2002). It is not yet
known where the mecA gene came from initially, however, it is believed to be horizontally
transferred from a strain resistant to methicillin to strains susceptible to methicillin, allowing the
resistance to actively spread.

5

2.1.2 Risk Factors
Poverty has long been associated with an increased risk of infectious disease acquisition
and transmission. Effective sanitation and hygiene techniques efficiently reduced the burden of
infectious disease prior to the development of antibiotics. However, with the use of antimicrobials
and effective sanitation, disinfection, and hygiene practices in today’s society, infectious diseases
continue to prevail. There are multiple reasons as to why MRSA infections emerge and why some
people are more likely to become colonized carriers of MRSA and others are not.
MRSA Infection
The emergence of MRSA infections can be due to several factors including social factors
and environmental settings. Several studies reported previous hospitalization as a risk factor for
the development of active MRSA infections (Böcher et al., 2008; Cadena et al., 2016; Graffunder
& Venezia, 2002), while other studies attributed a longer length of stay in the hospital due to the
emergence of a MRSA infection (Yao et al., 2015). In regard to social factors, Bagger et al.
reported that post-operative MRSA infection was associated with social deprivation score, and
members from the most socially deprived areas were seven times more likely to acquire an
infection compared to members of the least socially deprived areas (Bagger et al., 2004). In
addition, women were over two times more likely to acquire a post-operative MRSA infection
(Bagger et al., 2004). Surgery itself has been reported to be a risk factor for MRSA infections as
well (Cadena, Thinwa, Walter, & Frei, 2016; Graffunder & Venezia, 2002). In many cases,
following hospital admission and surgical procedures, it is common practice to prescribe oral
antibiotics. The prescription and recent use of antibiotics is also considered a risk factor for the
development of a MRSA infection by multiple authors (Böcher et al., 2008; Catry et al., 2014;
Graffunder & Venezia, 2002). Additional risk factors for MRSA infection include underlying skin
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diseases, enteral feedings, use of a respirator, admission to long term care settings, and the use of
antimicrobial agents (Böcher et al., 2008; Catry et al., 2014; Graffunder & Venezia, 2002; Yao et
al., 2015). Lastly, a significant risk factor for MRSA infections is colonization and nasal carriage
of MRSA (Cadena et al., 2016; Gupta et al., 2007; Stenehjem & Rimland, 2013; Yano et al., 2009).
Yano et al. (2009) found that patients colonized with MRSA had a significantly higher occurrence
of post-operative surgical site infection with MRSA than patients who were not colonized (Yano
et al., 2009). Cadena et al. (2016) found that MRSA colonization led to an increased risk of MRSA
skin soft tissue infections following hospitalization (Cadena et al., 2016). A summary of the risk
factors associated with MRSA infections can be found on Table 2.1.
Table 2.1: Risk factors for MRSA infection
Risk Factor

Reference(s)

Previous Hospitalization

(Graffunder & Venezia, 2002)
(Böcher et al., 2008)
(Cadena et al., 2016)

Social Deprivation Score

(Bagger et al., 2004)

Surgery

(Cadena, 2016)
(Graffunder, 2002)

Antibiotic Use

(Graffunder & Venezia, 2002)
(Böcher et al., 2008)
(Cary et al., 2014)

MRSA Colonization

(Yano, 2009)
(Stenehjem & Rimland, 2013)
(Gupta et al., 2013)
(Cadena, 2016)
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MRSA Colonization
The recent rise of MRSA colonization has led to further investigation of the risk factors
that can cause individuals to become MRSA carriers, with the potential of developing a lifethreatening infection later in life. Similar to the risk factors for MRSA infection, hospitalization
within the past twelve months, a skin infection at the time of hospital admission, antimicrobial use,
and being HIV positive have all been reported to be risk factors for MRSA colonization (Hidron
et al., 2005). Hospitalization within the past year was also found to be a risk factor for MRSA
colonization in two of the papers written by Jernigan et al. (2003), in conjunction with admission
to a long-term living facility, specifically a nursing home, and the presence of at least one
underlying chronic illness (Jernigan, Pullen, Partin, & Jarvis, 2003). Sassmannshausen et al.
(2016) found additional risk factors for MRSA colonization that consisted of: a history of MRSA
carriage, being a nurse or having an ICU occupation, having contact with MRSA carriers, homecare of relatives, having acne, having chronic inflammatory bowel disease, contact with a domestic
animal and with raw meat, and having an acute illness (Sassmannshausen et al., 2016). MRSA
colonization has many risk factors different from MRSA infection, however, hospitalization within
the previous year and antimicrobial use play a significant role in increasing the risk of both MRSA
infections and MRSA colonization.
2.1.3 MRSA Nasal Colonization
MRSA nasal colonization is the carriage of MRSA in the anterior nares, usually
asymptomatically. Although colonization can occur at other sites of the body such as the hands,
skin, underarms and intestinal tract, colonization in the nares has been found to be more consistent
when isolating MRSA (Dulon et al., 2014; Kluytmans J et al., 1997). MRSA and susceptible S.
aureus have an increased ability to adhere to the epithelial cells in the nares, in addition to the nose
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providing an environment where the organism can proliferate and survive for prolonged periods
of time (Kluytmans J et al., 1997). There are currently four different statuses identified and are
used to classify individuals based on their carriage: 1) Non-carriers, 2) persistent carriers, 3)
intermittent carriers and 4) transient carriers. Persistent carriers are individuals who chronically
carry only one strain, intermittent carriers are individuals who carry different strains for short time
periods, and non-carriers who almost never carry S. aureus at all (Dulon et al., 2014). Statuses can
often change within an individuals’ life-time, and most individuals’ pattern of carriage changes
when they are between the ages of ten and twenty (Kluytmans et al., 1997). Health-care workers
who may constantly be exposed to MRSA can become carriers during or after a work shift and
lose carriage of the pathogen before the next shift, these health-care workers are considered to be
transient carriers (Dulon et al., 2014). If a health-care worker has chronic dermatitis or sinusitis,
their chances of becoming persistent carriers increases, however most health-care workers fall
within the transient carriage status (Dulon et al., 2014).
Colonization with MRSA has consistently been found to increase the risk of developing an
active MRSA infection. When colonization in the nares occurs, it allows for the pathogen to spread
to other sites of the body (Kluytmans et al., 1997). In health-care settings, colonization in healthcare workers becomes increasingly significant because they become a potential source for
transmission to patients who may or may not be immune-suppressed and can increase the chance
of a patient developing a MRSA infection. Health-care workers who work in units with constant
exposure to MRSA are more likely to be colonized with MRSA (Muder et al., 1993). Although
health-care workers are likely to be transiently colonized, they may serve as vectors in the
transmission of MRSA (Dulon et al., 2014). The CDC estimates 33% of people carry susceptible

9

S. aureus in their anterior nares, and about 2% of the population can be colonized with MRSA
(Centers for Disease Control and Prevention, 2017).
2.1.4 HA-MRSA & CA-MRSA
Healthcare-associated or Hospital-associated MRSA are MRSA strains that are typically
transmitted and acquired in a health-care setting. Risk factors for HA-MRSA infections include
hospitalization, residence in a nursing home or other long-term care facility, surgery, dialysis, and
the presence of a foreign device such as a catheter (David & Daum, 2010; Huang et al., 2006).
HA-MRSA are known to be resistant to multiple antibiotics including non-beta-lactam antibiotics
through the genetic elements type II and type III staphylococcal cassette chromosomes (SCCmec
II-III)(David & Daum, 2010). Common variants of HA-MRSA strains include USA100 and
USA200. MRSA was identified in the 1960’s and was associated with the health-care setting,
however in the mid 1990’s MRSA outbreaks were being observed in communities affecting
healthy patients and people lacking risk factors known to be associated with MRSA (David &
Daum, 2010; Hsiao et al., 2015). It was soon discovered the strains responsible for community
MRSA outbreaks are distinctively different than HA-MRSA and were termed Communityassociated MRSA (CA-MRSA). CA-MRSA are genetically different than HA-MRSA. While HAMRSA contain SCCmec II-III, CA-MRSA contain SCCmec IV and V, and in addition, carry the
Panton Valentine gene (PVL) (Hsiao et al., 2015). The PVL gene is a virulence factor responsible
for the production of a cytotoxin that can cause tissue necrosis and leukocyte destruction (Adler,
Temper, Block, Abramson, & Moses, 2006). The most common variants of CA-MRSA are strains
USA300 and USA400. HA-MRSA affects patients in long-term care facilities, who have recently
been hospitalized and those who have undergone surgery, however, CA-MRSA affects young and
healthy people usually in the form of skin and soft tissue infections who have not been exposed to
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the health-care setting at all (Huang et al., 2006). Most infections caused by CA-MRSA are not as
resistant and difficult to treat as many HA-MRSA and are susceptible and treated with weaker
antibiotics than HA-MRSA infections (Hsiao et al., 2015). The differences between HA-MRSA
and CA-MRSA can be seen on Table 2.2. The emergence of CA-MRSA has drawn attention due
to its ability to rapidly disseminate across communities and entering the health-care setting,
replacing HA-MRSA strains and being transmitted within the hospital environment (David &
Daum, 2010).
Table 2.2: Differences between HA-MRSA and CA-MRSA
Healthcare-Associated MRSA

Differences

Community-Associated MRSA

Healthcare/Hospital setting

Acquisition

Community Setting

Hospitalization, residence in a
long-term care facility, surgery,
dialysis, presence of foreign
device (catheter)

Risk Factors

Close contact with community
members
Skin and soft tissue infections
Poor hygiene

High resistance to multiple
antibiotics
SCCmec II & III
Vancomycin, Daptomycin,
Linezolid, Tigecycline
USA100 & USA200

Resistance
Genetic Elements
Treatment
Antibiotics
Variants

Not as resistant
SCCmec IV & V
Panton Valentine gene (PVL)
Doxycycline, Clinamycin,
Bactrim
USA300 & USA400

2.1.5 Treatment and Prevention
Due to MRSA’s resistant and highly pathogenic nature, treatment of MRSA is often
challenging, costly and aggressive. Treatment of MRSA includes incision and drainage of the
11

abscess, if treating a skin and soft-tissue infection (Gilboy, 2011). In addition, surgical
debridement may be necessary to remove dead tissue of the abscess (Hessen, 2017). Medications
used to treat MRSA include antibiotics, both intravenous (IV) and oral, and some oils as well as
clay have been found to be effective against MRSA and can be used as a non-drug therapy to treat
MRSA infections. The first line of IV therapy is Vancomycin but also includes daptomycin,
linezolid, tigecycline, and quinupristin/dalfopristin (Gilboy, 2011; Hessen, 2017; Simor & Loeb,
2004). Oral antibiotics can also be used to treat MRSA and include trimethoprim-sulfamethoxazole
(TMP-SMX), clindamycin, tetracycline/doxycycline/minocycline, linezolid and rifampin (Gilboy,
2011; Simor & Loeb, 2004; Hessen, 2017). Each antibiotic is different, requires different dosages,
and is administered for different time periods. When a MRSA infection involves a foreign body,
such as a prosthesis, the foreign body may have to be removed in addition to administering
antibiotics. Non-drug therapies that have been studied and observed to inhibit growth and combat
MRSA include lemongrass essential oil, tea-tree oil, and French clay (Gilboy, 2011). Patients
infected with HA-MRSA often require more aggressive therapy than patients infected with CAMRSA, this is due to the differences in genetic elements that cause HA-MRSA to confer higher
resistance. Vancomycin is usually the first-line of treatment for HA-MRSA infections but can also
be treated with Daptomycin, Linezolid, and Tigecycline. CA-MRSA infections are often treated
with Doxycycline, Clindamycin and Bactrim, along with educating the patient on wound care and
proper hygiene (PACOSM, 2017).
When treating patients nasally colonized with MRSA, decolonization is not strongly
advised or enforced. In certain circumstances such as being a health-care worker and having close
contact with immunocompromised patients, being immunocompromised, and living in institutions
such as mental institutions and prisons, decolonization may be advisable (Gilboy, 2011). One
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method of decolonization is by washing with chlorhexidine or hexachlorophene if used in
conjunction with mupirocin (Gilboy, 2011). Placing mupirocin in the nostrils twice or thrice daily
for seven or six days has also been proven to be effective in decolonization of MRSA (Gilboy,
2011; Sassmannshausen et al., 2016).
Clinicians, health-care workers and community members must take proper precautions in
order to avoid and halt the transmission of MRSA. Clinicians often use hand sanitizer or
antibacterial solutions to clean their hands between patient visits, however, it is recommended to
wash hands properly with soap and water in between patient visits to effectively clean their hands
and avoid transmitting the agent to other patients (Gilboy, 2011; Simor & Loeb, 2004). In addition
to hand washing in between patients, the use of hand gloves are recommended to use when coming
in contact with patients and are to be removed immediately after the interaction to avoid the
transmission of infectious agents (Gilboy, 2011). If necessary, additional personal protective
equipment may be used such as disposable gowns, masks and eye protection (Gilboy, 2011). In
health-care settings, effective screening and surveillance techniques are recommended to identify
persistent MRSA carriers, and decolonization efforts are suggested (Simor & Loeb, 2004). In
community settings, proper disinfection and sanitation of athletic equipment and the proper care
of wounds is recommended, in addition to precautionary measures when someone in the
community acquires a MRSA infection (Hessen, 2017).

2.2 U.S./Mexico Border Region
2.2.1 Definition and Characteristics
The U.S.-Mexico border region is defined by U.S. Public Law and the La Paz Agreement
of 1983 as the area comprising 62 miles north and south of the border, extending over 2,000 miles

13

long from California to the Gulf of Mexico (Rivera et al., 2009; Velasco, 2014). The border region
consists of 44 U.S. counties and four U.S. states, California, New Mexico, Arizona and Texas, and
80 Mexican municipalities along with six Mexican states, Baja California, Sonora, Chihuahua,
Nuevo Leon, and Tamaulipas (Velasco, 2014).
The border region is home to about 15 million residents living on both sides of the border
(Pan American Health Organization, 2012). Approximately 25% of residents living in U.S. border
counties fall at or below the poverty line, which is more than double for the national average of
12% of people living in poverty (Migration Policy Institute, 2006). In addition, unemployment
rates are higher in the U.S. border area, 5.6%, compared to the rest of the United States, 4.7%
(Migration Policy Institute, 2006). However, Mexican states located on the border region have a
much lower poverty percentage of 28%, compared to the Mexican national average of 37%
(Migration Policy Institute, 2006). Due to high fertility in the border region, the population of both
sides of the border is relatively young with 30% of the Mexican border population and 24% of the
U.S. border population being under 15 years old (Pan American Health Organization, 2012). Life
expectancy on both sides of the border is about 3% above the average of both countries (Pan
American Health Organization, 2012).
Thousands of border crossings occur on a day-by-day basis for various reasons. Border
crossings continue to fluctuate throughout the years, rising by 43% from 1995 to 1999, and falling
21% by 2004, then rising again by 63% in 2006 (Pan American Health Organization, 2012;
Migration Policy Institute, 2006). Due to the frequent high mobility across the U.S.-Mexico
border, the border region faces unique health challenges and disparities that disproportionally
affect the border area compared to the rest of the United States and Mexico. Maternal mortality
rates continue to be higher in the border region when compared to national averages, with Texas
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having the highest maternal mortality rates, 22.2% in 2008, compared to the national average of
12.7% and 62.9% of maternal deaths in Chihuahua for the year 2008 compared to the Mexican
national average of 59.7% (Pan American Health Organization, 2012). The number one cause of
death in both the Mexican side of the border region and the United States side is diseases of the
heart (Pan American Health Organization, 2012). Right below diseases of the heart, malignant
neoplasms at number two and diabetes Mellitus at number 6 in the U.S. and number 3 in Mexico
follow (Pan American Health Organization, 2012). The border health commission identified six
strategic priorities which included access to care, tuberculosis, obesity and diabetes, and infectious
diseases (Velasco, 2014).
Vector borne diseases, sexual transmitted diseases and infectious diseases such as
tuberculosis continue to prevail and cause concern in the border region. In 2010, of all West Nile
virus cases that occurred throughout the United States, 40% of the cases occurred in the four border
states (Pan American Health Organization, 2012). The incidence rate in Arizona and Texas for
HIV/AIDS were significantly high in 2009, being 10.2 cases per 100,000 population in Arizona
and 17.1 cases per 100,000 population in Texas. Congenital syphilis incidence rates were highest
in the Mexican border region in 2010 when compared to the rest of Mexico, 30 cases per 100,000,
and highest in Texas at 25.3 per 100,000 population when compared to the rest of the United States
(Pan American Health Organization, 2012). Tuberculosis incidence rates were highest in
California in 2009 with 6.7 new cases per 100,000 population, followed by Texas with 6.1 new
cases of tuberculosis per 100,000 population (Pan American Health Organization, 2012). Baja
California reported having an incidence rate of 38.3 per 100,000 population compared to the
national average of 13.5 (Pan American Health Organization, 2012). In response to the many
illnesses that prevail in the border region, both infectious and chronic, access to health care
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continues to be a major reason to cross the U.S.-Mexico border every single day for millions of
people (Rivera et al., 2009).
2.2.2 Antibiotic Resistance and Consumption
Antibiotic resistance has burdened and interfered with treatment of patients since
antibiotics were first introduced to the public in the 1940’s. The development of new antibiotics
has aided in combatting resistant organisms only slightly. The mechanisms of resistance change at
a pace too fast for antimicrobial therapy to catch up. Emerging resistance mechanisms have
primarily been attributed to antibiotic overuse and inappropriate prescribing, as well as its heavy
use in agriculture (Ventola, 2015). Chambers and DeLeo describe the history of S. aureus
antibiotic resistance in four “waves.” The first wave of resistance occurred when S. aureus grew
resistant to penicillin through the plasmid-encoded penicillinase (Chambers & DeLeo, 2009). The
second wave of S. aureus resistance occurred 20 years later with the first published report of
resistance to methicillin through the action of PBP 2a (Chambers & DeLeo, 2009). In response to
the overwhelming presence of HA-MRSA in health-care settings, the use of vancomycin surged
and in result, vancomycin-resistance S. aureus (VRSA) appeared marking the beginning of the
third wave of resistance (Chambers & DeLeo, 2009). The final and current wave of S. aureus
resistance is due to the rapid spread of MRSA in communities, as previously described in section
2.1.4.
The emergence of these waves of resistance have continuously burdened the health-care
system making infections harder to treat, while increasing cost and length of hospitalization for
patients (Vonberg et al., 2006). Antimicrobial resistance has demonstrated its ability to rapidly
disseminate across communities and is considered a global threat to public health (Gartin, Brewis,
& Schwartz, 2010). The high mobility of people crossing the US/Mexico border, specifically the
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El Paso/Cd. Juarez border, on a daily basis cause a greater risk for infections and resistant
organisms to be transmitted in both directions (Rivera et al., 2009). In addition, many Mexican
residents and U.S. residents cross the border to obtain health care and pharmaceuticals. When
many U.S. patients cannot afford or obtain antibiotics on the U.S. side of the border, obtaining
them from Mexico is an often cheap and feasible strategy (Homedes & Ugalde, 2012). Until
recently, obtaining antibiotics from Mexican pharmacies was possible without a prescription,
resulting in the common practice of self-medication (Gartin et al., 2010). Now that antibiotics is
considered a controlled substance in Mexico, the problem has only slightly improved but has not
completely been eliminated.
Anyone can open and own a pharmacy and does not necessarily have to be a physician,
and the dispensing of antibiotics to patients who do not have prescriptions is not well controlled
(Homedes & Ugalde, 2012). In addition to dispensing pharmaceuticals, some Mexican pharmacists
who receive limited training can diagnose patients and prescribe medications for a small fee
(Homedes & Ugalde, 2012). Antibiotics continue to be one of the most sold pharmaceuticals on
both sides of the border supporting the assumption that over-prescription, over-dispense, and overconsumption continues to be an obstacle in fighting emerging antibiotic resistance. El Paso faces
a greater risk to emerging antibiotic resistance due to its geographical location, as it sits right next
to Mexico and has the largest U.S./Mexico border population (Rivera et al., 2009).
2.2.3 MRSA Infection Statistics
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United States
The Center for Disease Control and Prevention (CDC) has an Emerging Infections Program
(EIP) that tracks the national burden of MRSA using data from six states, California, Connecticut,
Georgia, Minnesota, New York, and Tennessee (Centers for Disease Control and Prevention,
2015). The most recent data tracks MRSA cases up until 2015, and reports the amount of cases
that were community-associated and hospital-associated. Healthcare-associated cases (HCA),
2,117, were significantly higher than community-associated (CA), 560, with healthcare-associated
community onset cases (HACO), 1,678, outweighing hospital-onset cases (HO), 493 (CDC, 2015).
Out of the 2,117 HCA infections, 279 (13%) resulted in deaths, while only 53 cases (9%) of the
560 CA cases resulted in deaths. The most frequent clinical syndrome associated with MRSA
infections among CA and HACO cases was bloodstream infection with other syndrome (CDC,
2015). The most frequent clinical syndrome among HO cases was bloodstream infection with no
other syndrome. The second most frequent syndrome in CA cases was cellulitis (CDC, 2015).
HACO and CA cases were highest among individuals greater than 65 years of age, while HO cases
were highest among infants less than 1 year of age. Comparing the data to 2014, the overall
incidence of healthcare-associated MRSA decreased by 10% (CDC, 2015).

Texas
The Texas Department of State Health Services (DSHS) has MRSA statistics available
from 2012 to 2014 but state their data is limited. Table 2.2 illustrates the data obtained from the
Texas DSHS.
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Table 2.3: Texas DSHS MRSA Statistics
Year
2012

No. of S. aureus
isolates
609 isolates

No. (%) of MRSA
isolates
274 isolates (45%)

2013

790 isolates

438 isolates (55.45%)

2014

710 isolates

395 isolates (55.67%)

According to the data provided by the Texas DSHS, although the amount of S. aureus
isolates decreased from 2013 to 2014, overall MRSA percentage has been steadily increasing
(Texas Department of State Health Services, 2017).
Through the CDC’s National Healthcare Safety Network, Healthcare-associated infections
are tracked and reported by state. The Texas report includes several healthcare-associated
infections including MRSA bacteremia based on 2014 data. The total amount of hospitals included
in the Texas healthcare-associated infections report was 372 hospitals. From 2013 to 2014, Texas
hospitals reported no significant change in MRSA bacteremia (Centers for Disease Control and
Prevention, 2016). The standardized infection ratio (SIR) for U.S. was calculated to be 0.87, and
among the 163 Texas hospitals with enough data to calculate an SIR, 7% had an SIR significantly
worse than the national SIR (CDC, 2016). However, the 2014 state SIR was 0.83, slightly lower
than the national average and 0.04% lower than the 2013 state SIR (CDC, 2016).

El Paso
In order for hospitals to obtain payment from Medicare, Medicare requires hospitals to
submit data on healthcare-associated infections and then allows customers to access the data
through their website, medicare.gov, in order to be used to compare different hospitals of interest.
Medicare considers the Texas SIR rate to be 0.886, and compares the hospitals to that number. El
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Paso hospitals’ SIR for laboratory-identified MRSA bloodstream infections can be found on Table
2.3.
Table 2.4: El Paso Hospitals’ Standardized Infection Ratio for MRSA
Hospital Name

Hospital SIR

University Medical Center of El Paso
Las Palmas Medical Center
The Hospitals of Providence Memorial Campus
Sierra Providence East Medical Center
a

1.177
1.225
0.268
1.083

Texas SIRa

0.886

According to Medicare.gov

The hospitals with available data were included in Table 2.3. Three of the four hospitals’ SIR for
laboratory-identified MRSA bloodstream infections were above the state SIR of 0.886 (Medicare,
2017).
O’Brien et al. (2005) studied multiple-antibiotic-resistant MRSA isolates obtained from
Las Palmas and Del Sol medical center of El Paso during June to August of 2002. Using a disk
diffusion assay the MRSA isolates resistant to three or more classes of antibiotics were considered
to be multiple-antibiotic-resistant MRSA clones (O'Brien et al., 2005). The study concluded by
stating there is a presence of a multiple-antibiotic-resistant MRSA epidemic in El Paso, Texas
(O’Brien et al., 2005). According to a study investigating the prevalence of MRSA on both sides
of the El Paso/Cd. Juarez border, El Paso had a significantly higher prevalence of MRSA when
compared to Juarez, and over a third of the MRSA isolates were community-associated (Rivera et
al., 2009). Benoit et al. studied antimicrobial resistance trends using eight hospitals in three states
at the U.S.-Mexico border from 2000 to 2006. Six different pathogens were studied, however of
the six pathogens, resistance was highest among S. aureus isolates with 45.7% of all S. aureus
isolates being resistant to oxacillin (Benoit, Ellingson, Waterman, & Pearson, 2013). The majority
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of MRSA isolates were isolated from skin and soft tissue infections, and significantly increased
from 14% in 2000, to 65.6% in 2006 which indicates an increasing presence of CA-MRSA at the
border region (Benoit et al., 2013).
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Chapter 3: Goal and Objective
3.1 Goal and Objective

The goal of this project is to determine the prevalence of S. aureus and MRSA nasal
colonization among first-year medical students, at an osteopathic school of medicine located in
the Southern U.S./Mexico Border region. The objective of this project is to establish the carrier
status of first-year osteopathic medical students by conducting nasal swabs on the participants
and characterizing the bacteria through selective media and mecA gene amplification.
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Chapter 4: Study Aims and Hypothesis
4.1 Aims

Aim 1: Examine the risk factors associated with Methicillin-Resistant S. aureus.
Aim 2: Identify the prevalence of S. aureus and MRSA nasal carriage among incoming medical
students by obtaining nasal swabs, culturing the swabs, and performing PCR.

4.2 Hypothesis

Hypothesis: The prevalence of students colonized with MRSA will be higher than the CDC
estimate of 2% of the population due to students having greater amounts of previous healthcare
exposure hours.
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Chapter 5: Methods and Materials
5.1 Sample Collection & Recruitment
This research project is in collaboration with Burrell College of Osteopathic Medicine
(BCOM) The study aims to recruit incoming first-year medical students attending (BCOM),
willing to participate throughout their four years in medical school, and non-medical graduate
students attending New Mexico State University (NMSU) to serve as controls. The study is a
cohort, longitudinal study, and data will be collected once a year for four years. A nasal swab and
a survey will be obtained from the participants, beginning November of 2017 and every year
thereafter. BCOM researchers conducted a power analysis to calculate the sample size needed to
have a representative sample and resulted in a minimum of 41 participants, however, the study
aims to recruit a total of 82 participants to maintain the integrity of the study.
The subject participants were recruited during their school’s new student orientation and
were given a presentation about the study. Burrell College of Osteopathic Medicine’s Institutional
Review Board reviewed and approved the proposed protocol #BCOM IRB 00012_2017 entitled
“Rate of MRSA Acquisition in Medical Students from Pre-Clinical to Clinical Years” (Appendix
1). All participants were given a participant survey to complete (Appendix 4). The medical
students who agreed to participate in the study were added to their institution’s Canvas Learning
Management System’s online course created specifically for the study, where they will
electronically complete the survey. After completing the survey, participants were assigned a
random four-digit number. Study participants arranged a date with investigators to have nasal
swabs performed and where informed consent forms were signed (Appendix 3). The nasal swabs
were then labeled with the participant’s assigned number. Recruitment and sample collection was
conducted by the BCOM research team. The control participants were recruited during a graduate
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school meeting where they signed the consent form, completed the participant survey, and nasal
swabs were obtained. UTEP did not have any interaction with study participants or collection of
nasal swabs. Due to the samples and survey results being de-identified before arriving at UTEP,
UTEP’s protocol is exempt and relies on BCOM’s IRB (Appendix 2).
Nasal swabs were transported to Dr. Dominguez laboratory at the college of Health
Sciences immediately after collection. The nasal swabs were then cultured on selective media and
characterized phenotypically and molecular techniques were used to detect the gene associated
with MRSA strains.
5.2 Bacterial Growth & Identification
The media used to culture the nasal swabs was Mannitol Salts Agar (MSA) ), which is a
selective medium for the isolation of S. aureus (Sigma-Aldrich’s). The high concentration of salt
in MSA media supports the growth of Staphylococcus species, while inhibiting the growth of many
other organisms (EMD Millipore, ). S. aureus will produce yellow colonies and turn the phenol
red agar yellow by fermenting the mannitol and is the first indication of S. aureus (EMD
Millipore). The swabs used for the nasal swabbing were directly used to streak for isolation on
the MSA media. Cultures were incubated at 35°C for 24-48 hours to allow for sufficient growth.
Yellow colonies were subcultured onto Trypticase Soy Agar (TSA) in order to allow for sufficient
growth in order to store the organisms in Microbank Beads Bacterial Preservation Systems (ProLab Diagnostics TM). Since other Staphylococci species may produce a clumping factor, a tube
coagulase test was performed to confirm identification of S. aureus using BBL Coagulase Plasma,
Rabbit with EDTA (Beckton, Dickinson and Company). If the organism produced
Staphylocoagulase, an extracellular molecule that causes clot formation, a positive reaction would
be demonstrated by a development of a clot. The DNA of the positive organisms was then
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extracted, and PCR was performed. A representation of the methods process can be seen in Figure
5.1.
5.3 Molecular Identification by mecA Gene Amplification
5.3.1 DNA Extraction
One Microbank bead was inoculated into 10ml of Luria Broth and placed in the shaker
overnight at 35°C. After 18 hours, the DNA of the organism was extracted using Qiagen’s DNeasy
Blood and Tissue kit according to the manufacturer’s instructions for gram-positive bacteria
(Qiagen Inc., Valencia, CA). The integrity of the extracted DNA was assessed by electrophoresis
at 140V on a 1% agarose gel for 30 minutes. DNA was visualized by Ethidium Bromide (0.5µl).

5.3.2 Polymerase Chain Reaction (PCR)
Polymerase Chain Reaction (PCR) was performed to amplify the mecA gene. Table 5.1
illustrates the forward and reverse primers that were used (Al-Haddad, Udo, Mokadas, Sanyal, &
Grubb, 2001). Cycling parameters were as follows: 1 cycle denaturation 94°C for 1 minute,
annealing 55°C for 30 seconds, and extension72°C for 90 seconds, 30 cycles(Al-Haddad et al.,
2001). S. aureus ATCC 29213 and E. coli ATCC 25922 were used as negative controls and S.
aureus ATCC 43300 was used as a positive control along with the universal primer 16S rDNA as
the internal control (Rivera et al., 2009). The PCR product was visualized on a 2% agarose gel
through electrophoresis at 140V for 60 minutes with 0.5µl of Ethidium Bromide.
Table 5.1: Primer sequences used and expected band sizes.
Primer

Sequence (5’-3’)

Reference

mecAfw

AAAATCGATGGTAAAGGTTGGC

mecArv

AGTTCTGCAGTACCGGATTTGC

(Al-Haddad et
al., 2001)
(Al-Haddad et
al., 2001)
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Figure 5.1: A visual representation of the methods process.

5.4 Statistical Analysis
The survey administered to participants was developed by BCOM researchers and asked
participants to provide information about their demographics, social characteristics, and medical
history (Appendix 4). In the demographics section, the participants were asked to provide their
name and age, whether they were osteopathic medical students year one, two, three or four, and to
identify their ethnicity as one of the following: African American, Hispanic, Caucasian, Asian,
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Indian, Native American, or Other. Under social data, participants were asked to provide their
living situation which included: living alone, in a dorm with other medical students, in a dorm with
other non-medical students, with family, with others, homeless, or other. Participants were asked
whether they live with children under the age of 18, whether they have a dog or cat at home, or if
they have frequent contact with livestock such as cows, pigs, sheep or chickens. Participants were
asked whether they smoke daily or use any tobacco products and the frequency of such use, if they
care for a chronically-ill person at home, if they are currently employed, if they have prior
healthcare experience, and if so, participants were asked to describe and/or list those experiences.
Under the medical history section of the survey, participants were asked if they have any health
problems, if they are currently on a steroid regimen, and if they’ve taken steroids within the past
three weeks. Participants were asked if they have taken antibiotics within the past six months, if
so, they were asked to list the antibiotics taken, and if they always finish the entire course of
antibiotics when prescribed. Participants were then asked if they have been hospitalized within the
past six months, if they have had surgery within the past six months, if they have ever had a skin
infection, if they have ever been diagnosed with a MRSA infection, if they have ever had a
respiratory infection or pneumonia, and if they are currently ill.
The survey data was obtained from BCOM’s research team free of any personal identifiers
in the form of a comma-separated value (CSV) file. The data was imported into the statistical
software Statistical Package for Social Sciences (SPSS) and separate columns were added to
include the results of the nasal swab culture, coagulase test, and PCR analysis. The responses
obtained for the question labelled “Ethnicity” were recoded into two separate variables, Race and
Ethnicity. The levels used for the Race variable were obtained from the U.S. Census Bureau (U.S.
Department of Commerce, Economics and Statistics Administration, January 2017) and included
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White, Black/African American, American Indian/Alaska Native, Asian, Native Hawaiian/Pacific
Islander, and Other. Participants who stated their Ethnicity to be White, Caucasian, Hispanic,
Latino, Pakistani, and White Middle Eastern were identified as White. Participants who stated their
ethnicity as Asian Caucasian, White Asian, Taiwanese, Filipino American, and Chinese were
identified as Asian. Participants who stated their ethnicity to be Peruvian and Mexican were
identified as American Indian/Alaska Native. The levels for Ethnicity were obtained from the U.S.
Census Bureau (U.S. Department of Commerce, 2017) and included Non-Hispanic/Latino, and
Hispanic/Latino. Participants who explicitly stated their ethnicity to be Hispanic, Latino, Mexican,
or Peruvian were considered as Hispanic/Latino. All other participants were identified as NonHispanic/Latino.
A univariate analysis was conducted for each variable. For continuous variables that are
normally distributed, the sample size (n), mean, and standard deviation (SD) were reported. For
continuous variables that are not normally distributed, the sample size (n), minimum, Q1, median,
Q3, and maximum were reported. For categorical variables, the sample size, frequency and
percentages were reported.
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Chapter 6: Results
The results in Table 6.1 display the results obtained for the univariate analyses. The
results are separated into four categories, sociodemographic characteristics, social characteristics,
medical history, and laboratory results.
Table 6.1: Univariate Analysis Results
PARTICIPANT SURVEY QUESTIONS

ALL PARTICIPANTS
N
Mean
SD Missing (freq)
N Median
(Q1,Q3) Missing (freq)
N
Freq
% Missing (freq)

Sociodemographic Characteristics
Group

N
N
N

SUBJECTS ONLY
Mean
SD Missing (freq)
Median
(Q1, Q3) Missing (freq)
Freq
% Missing (freq)

CONTROLS ONLY
N
Mean
SD Missing (freq)
N Median
(Q1, Q3) Missing (freq)
N
Freq
% Missing (freq)

36
Subject
Control

Age
Gender

36
36
Female
Male

Race

32
4
24

88.9%
11.1%
(23, 27)

20
16

55.6%
44.4%

29
0
2
5
0
0

80.6%
0.0%
5.6%
13.9%
0.0%
0.0%

27
9

75.0%
25.0%

5
1
8
11
9
2
2

13.9%
2.8%
22.2%
30.6%
25.0%
5.6%
5.6%

32
32

36
White
Black/African American
American Indian/Alaska Native
Asian
Native Hawaiian/Pacific Islander
Other

Ethnicity

Social Characteristics
Living Situation
With Other Medical Students
With Other non-Medical Students
With Family
With Others
Alone
Other
Living with children <18 years old
Living with pets
Dog
Cat
Frequent Contact with Livestock
Daily Tobacco Use
Care for a Chronically Ill Person at Home
Currently Employed
Prior Healthcare Experience
Prior Approx. Healthcare Exposure Hours
Medical History
Underlying Medical Conditions
On a Current Steroid Regimen
Steroid Administration Within the Past 3 Weeks
Antibiotic Administration Within the Past 6 mo.
Antibiotic Course Completion Rate
Hospitalization Within the Past 6 mo.
Surgery Within the Past 6 mo.
Ever Had a Skin Infection
Ever Been Diagnosed with a MRSA Infection
Ever Had a Respiratory Infection/Pneumonia
Currently Ill
Laboratory Results
Positive Culture
Coagulase Test
Positive
Negative
PCR
Positive
Negative

36
36
36
36
36
19

17
15

53.1%
46.9%

26
0
2
4
0
0

81.3%
0.0%
6.3%
12.5%
0.0%
0.0%

25
7

78.1%
21.9%

5
1
8
10
7
1
2

15.6%
3.1%
25.0%
31.3%
21.9%
3.1%
6.3%

4
4

10
27.8%
7
19.4%
0
0.0%
1
2.8%
0
0.0%
5
13.9%
30
83.3%
2,220 (300, 5070)

35
36
36
36
36
35
36
35
36
36
36

3
1
1
7
32
2
1
14
1
14
1

8.3%
2.8%
2.8%
19.4%
88.9%
5.6%
2.8%
38.9%
2.8%
38.9%
2.8%

36
12

12

33.3%

12
0

100.0%
0.0%

0
12

0.0%
100.0%

32
32
32
32
32
19

11
1

1
1

12

3
1

75.0%
25.0%

3
0
0
1
0
0

75.0%
0.0%
0.0%
25.0%
0.0%
0.0%

2
2

50.0%
50.0%

0
0
0
1
2
1
0

0.0%
0.0%
0.0%
25.0%
50.0%
25.0%
0.0%

4
4
4
4
4
1

1
3
0
1
0
4
1
0

25.0%
75.0%
0.0%
25.0%
0.0%
100.0%
25.0%
0

4
4
4
4
4
4
4
4
4
4
4

0
0
0
1
3
0
0
2
0
1
0

0.0%
0.0%
0.0%
25.0%
75.0%
0.0%
0.0%
50.0%
0.0%
25.0%
0.0%

4
2

2

50.0%

2
0

100.0%
0.0%

0
2

0.0%
100.0%

4

9
28.1%
4
12.5%
0
0.0%
0
0.0%
0
0.0%
1
3.1%
29
90.6%
2220 (300, 5070)

31
32
32
32
32
31
32
31
32
32
32

3
1
1
6
29
2
1
12
1
13
1

9.4%
3.1%
3.1%
18.8%
90.6%
6.3%
3.1%
37.5%
3.1%
40.6%
3.1%

32
10

10

31.3%

10
0

100.0%
0.0%

0
10

0.0%
100.0%

10

30

3

4

32

32
32

25.5

4

32

36

36
36

3.119

32

36
Non-Hispanic/Latino
Hispanic/Latino

25

4
4

10
1

1
1

2

1

6.1 Descriptive Statistics
6.1.1 Sociodemographic Characteristics
The variables were derived from questions included in the participant survey administered
by BCOM researchers. The sample consisted of 36 participants (n=36), men (n=16) and women
(n=20). 32 of those participants were subjects (88.9%) and 4 participants were controls (11.1%).
The median age for both subjects and controls was 24 years (IQR: 23, 27).
The majority of participants identified as being White (80.6%), five participants identified
as being Asian (13.9%), and two participants identified as being American Indian/Alaska Native
(5.6%). The Ethnicity variable consists of two levels, Non-Hispanic/Latino (75%) and
Hispanic/Latino (25%).

6.1.2 Social Characteristics
For living situation, participants reported living with other medical students (19.9%), with
other non-medical students (2.8%), with family (22.2%), with others (30.6%), alone (25%), and
other (5.6%). Two participants reported living with children under 18 years old (5.6%).
Participants reported having a dog (27.8%) or a cat at home (19.4%).
No participants reported having frequent contact with livestock. One participant reported
the daily use of tobacco (2.8%). No participants reported caring for a chronically ill person at
home. Five participants reported being currently employed (13.9%). Most participants reported
having prior healthcare experience (83.3%). The median amount of healthcare exposure hours for
students who reported having prior healthcare experience was 2.220 hours (IQR: 300, 5070), 11
participants did not provide an approximate amount of prior healthcare exposure hours.
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6.1.3 Medical History
Few participants reported having an underlying medical condition (8.3%). One participant
reported being on a current steroid regimen (2.8%), and one participant reported having taken
steroids within the past three weeks (2.8%). Seven participants reported having taken antibiotics
within the past six months (19.4%) and the majority of participants reported always completing
the antibiotic course when prescribed (88.9%). Two participants reported being hospitalized within
the past six months (5.6%), and one participant reported having had surgery within the past six
months (2.8%). Fourteen participants reported ever having a previous skin infection and a
respiratory infection (38.9%). Only one participant reported ever being diagnosed with a MRSA
infection (2.8%). One participant reported being currently ill at the time of the survey
administration (2.8%).

6.1.4 Laboratory Results
Of the 36 nasal swab samples received, 12 (33.3%) samples resulted in having positive
cultures for S. aureus. Of those twelve positive culture samples, all 12 (100%) samples resulted in
being coagulase positive confirming the presence of S. aureus. Of the 12 positive S. aureus
samples, none of the isolates resulted in having the mecA gene (0%) therefore, none of the samples
were positive for MRSA. Images of samples resulting in positive culture results, with partial and
full mannitol fermentation, can be seen in Figure 6.1 and Figure 6.2. PCR results can be seen in
Figure 6.3.
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Figure 6.1: A culture plate from participant 2880, after 48 hours of incubation, resulting in partial
mannitol fermentation.

Figure 6.2: A culture plate from participant 2137, after 48 hours of incubation at 35C, resulting
in full mannitol fermentation.

Figure 6.3: A 2% gel displaying the products after a PCR run. From left to right, the wells
consist of the following: molecular ruler, [1] participant 1208-C, [2] participant 1270-C, [3]
participant 1159, [4] participant 2996, [5] participant 2853, [+] positive control, [-] negative
control, 16S universal internal control, molecular ruler.
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6.2 Participant Group Differences
The mean age for both the subject participants and control participants were very similar,
25 and 25.5 respectively. There was a small difference between genders in the subject group with
17 subjects being female (53.1%), and 15 subjects being male (46.9%). The majority of control
participants were Female (75%), and one participant was male (25%). The race variable was
similar between subjects and controls. Most participants identified as being White, subject
(81.3%), control (75%). Subjects also identified as being American Indian/Alaska Native (6.3%),
and Asian (12.5%). In addition to White, controls also identified as being Asian (25%). The
majority of Subjects identified as being Non-Hispanic/Latino (78.1%) rather than Hispanic/Latino
(21.9%). Half of the controls identified as Hispanic/Latino (50%).
When asked about their living situation, most subjects responded in living with others
(31.3%), living with family (25%), living alone (21.9%), living with other medical students
(15.6%), and living with other non-medical students or other (3.1%). Controls responded in living
along (50%), living with others (25%), and other (25%). Two participants responded in living with
children under 18 years of age (6.3%), while none of the controls responded in living with children
under 18 years of age (0%). Subjects and controls reported having a dog at home (28.1% and 25%),
and a cat at home (12.5% and 75%). One control participant reported the daily use of tobacco
(25%), while no subjects reported the daily use of tobacco (0%). Participants responded in whether
they are currently employed, subjects (3.1%) controls (100%). The majority of subjects reported
having prior healthcare experience (90.6%), while one control reported having prior healthcare
experience (25%). The median amount of prior healthcare exposure hours for subjects was 2,220
(IQR: 300, 5,070). The control participant who responded in having prior healthcare experience
did not provide an approximate amount of healthcare exposure hours.
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Subjects reported having underlying medical conditions (9.4%), while no controls reported
having underlying medical conditions. One participant reported being on a current steroid regimen
and having taken steroids within the past three weeks (3.1%), as opposed to zero controls (0%).
Both subjects and controls reported having taken antibiotics within the past six months (18.8% vs
25%). 90.6% of subjects reported always completing the antibiotic course when prescribed
antibiotics, compared to 75% of controls. Two subjects reported being hospitalized within the past
six months (6.3%), and having surgery within the past six months (3.1%), compared to no controls.
Both subjects and controls reported ever having a skin infection (37.5% vs 50%), and only subjects
reported ever being diagnosed with a MRSA infection (3.1%). Subjects and controls reported ever
being diagnosed with a respiratory infection or pneumonia (40.6% vs 25%). One subject was
currently ill during the time of the survey administration (3.1%).
31.3% of subjects’ nasal samples resulted in a positive culture. 100% of those positive
samples were confirmed to be S. aureus, however, none of them resulted in being positive for
MRSA. 50% of the control nasal swabs resulted in a positive culture. 100% of control-positive
cultures were coagulase positive and therefore confirmed to be S. aureus. None of the controlpositive samples were MRSA.
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Chapter 7: Discussion
7.1 Conclusions
A study conducted at a Louisiana medical university studied whether direct hospital
exposure in medical and graduate students versus pre-clinical medical students and graduate
students with no hospital exposure affected the nasal carriage rate of S. aureus. Students with
clinical exposure had a S. aureus colonization percentage of 25.1% and non-clinical students had
a colonization percentage of 7.14% (Wheeler & Morici, 2013).The nasal carriage percentage in
this thesis study compared to the Louisiana study is much higher in pre-clinical medical students
and slightly higher than students with clinical exposure. Similar to this study, none of the samples
were positive for MRSA.
Treesirichod, Hantagool, and Prommalikit (2013) studied nasal carriage of S. aureus in
pre-clinical medical students attending a medical school in Ongkharak, Thailand. 29.7% of the
participants were positive for nasal colonization of S. aureus, and out of 128 participants, none
were positive for MRSA nasal colonization (Trewesirichod, Hantagool, & Prommalikit, 2013).
The authors studied a similar group for S. aureus nasal colonization and although the percentage
is closer to that of this study, this study revealed a higher percentage of nasal colonization.
Zakai (2015) investigated Methicillin-susceptible S. aureus (MSSA) and MRSA
colonization in both medical students with clinical exposure and medical students with no clinical
exposure in Jeddah, Saudi Arabia (Zakai, 2015). The study revealed 100% of pre-clinical students
were colonized with MSSA, but none were positive for MRSA. Of students with clinical exposure,
18.7% were carriers of MSSA and 6.7% were carriers of MRSA. Although susceptible S. aureus
carriage was higher among pre-clinical medical students, higher MRSA prevalence was found
among students with clinical exposure (Zakai, 2015). This study resulted in a much higher S.
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aureus prevalence among pre-clinical medical students in comparison with our study, however
MRSA carriage results are similar to ours.
Previous studies on colonization percentages in medical students in their pre-clinical years
resulted in similar findings as this thesis study. Although all three studies found varying prevalence
of colonization, the studies demonstrated a trend of increasing S. aureus and MRSA prevalence
among students with clinical exposure in comparison to students in their pre-clinical years. Very
few pre-clinical students were MRSA positive. Although this thesis study focused on the
prevalence of colonization among first-year osteopathic medical students, the parent study aims to
continue collecting data on colonization rates as the same group of students as they transition from
their pre-clinical years to their clinical years in medical school. The studies discussed above found
differences in colonization percentages between pre-clinical and clinical students, however, none
of the studies were cohort studies, following the same group of individuals through their transition.
This thesis study found the prevalence of S. aureus nasal colonization among first-year,
pre-clinical medical students to be 31.3%, and 33.3% overall. The results are similar to the CDC
estimate of nasal colonization among healthy adults of 33% (CDC, 2017). The absence of MRSA
in a sample of 36 participants is similar to the CDC estimate of 2%, therefore I reject my
hypothesis.

7.2 Methodological Strengths and Limitations
7.2.1 Strengths
One of the methodological strengths of this thesis study is the administration of the
participant survey which consisted of questions addressing risk factors for colonization according
to previous literature. The participant survey gave insight to sociodemographic characteristics,
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social circumstances, and medical history which are beneficial in the data analysis. Another
methodological strength was the immediate plating of samples the same day of collection. In
addition, when the coagulase test was performed, the tubes were checked after four hours to
account for potential clot autolysis. The coagulase samples were checked again after 18 hours of
incubation.

7.2.2 Limitations
One of the methodological limitations of this study was the recruitment process of the
controls, resulting in only four controls being recruited. With a small control group that is not
similar to the subject group, analyses and comparisons were unable to be made in comparing the
two groups. Another methodological limitation to this study was the administration method of the
participant survey. When the participant survey was administered to the participants, it allowed
for participants to fill-in answers which led to multiple inconsistencies and missing information in
their responses. The questions that addressed participant ethnicity and prior amount of healthcare
exposure hours were not structured in a form that makes analysis reliable. The responses for
Ethnicity included several different responses, often times including nationality and not
necessarily ethnicity. Many responses for Prior Healthcare Experience Hours were not
approximations of the total amount of experience hours, but employment history and duration of
employment instead, and the approximate amount of healthcare exposure hours had to be
calculated.
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7.3 Analytical Strengths and Limitations
7.3.1 Strengths
The analytical strength of this thesis study is, in addition to gathering data on the prevalence
of S. aureus colonization, data was also gathered on risk factors and social characteristics to be
analyzed, which contributes to the understanding of S. aureus nasal colonization among first-year
osteopathic medical students.

7.3.2 Limitations
The analytical limitations of this thesis study is that the sample size was fairly small and
not representative of the study population. In addition, as a result of the variety of responses
received from the ethnicity question, the race and ethnicity the participant was considered may not
have been a true representation of that participant. For example, many students stated their
ethnicity as being White or Caucasian, and although their race was considered to be White, their
ethnicity was considered to be Non-Hispanic/Latino because it was not explicitly stated. However,
many of the participants identifying as White or Caucasian may in fact be of Hispanic ethnicity.
As discussed in the methodological limitations section, many participants stated their employment
history and duration instead of approximating their amount of prior healthcare exposure hours and
the approximation calculated may not be accurate. In addition, many participants stated their
employment history with no way of approximating hours. For example, a participant may have
stated they have experience working as an EMT for two years but did not give an amount of hours
per week and was therefore considered as missing data.
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7.4 Recommendations
Both the methodological and analytical strength and limitations in this thesis can guide
future studies when designing and developing a similar study.
Future recommendations for the laboratory analysis of the nasal samples include possibly
conducting disc diffusion assays to explore the susceptibility pattern of the S. aureus isolates. In
doing so, the degree of resistance present can be observed better and MRSA can be identified by
both PCR and cefoxitin resistance.
In addition, modifying the structure of the questions in the participant survey can be
beneficial when analyzing the data. The Ethnicity question can be separated into two separate
questions, Race and Ethnicity, according to the U.S. Census Bureau with answer choices within
the question. Doing so minimizes the amount of inconsistencies in the responses and the responses
are a more reliable representation of the sample. When asking participants about their prior
healthcare experiences, answer choices can be given with exposure hour ranges as responses.
Administering the survey online as an online exam can be beneficial by not allowing participants
to proceed if a question has not been answered. A few participants stated they had prior healthcare
experience, however when asked to approximate those hours and describe the experiences, the
question was left blank. By not allowing participants to skip questions, variables have fewer
missing values.
Lastly, prior to obtaining nasal samples from medical students, researchers can make sure
they have recruited enough control participants to provide samples as well in order to ensure
comparable sample sizes.
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Chapter 8: Strategic Frameworks
This thesis study is relevant to three strategic frameworks: Healthy People 2020, the City
of El Paso’s Community Health Assessment and Improvement Plan (CHA/CHIP), and the CDC’s
Framework for Preventing Infectious Diseases. Although a topic area of the Healthy Border 2020
strategic framework pertains to infectious diseases, none of the objectives listed related to reducing
nosocomial S. aureus/MRSA infections or surveillance of S. aureus/MRSA infections. None of
the priority areas listed in the Paso Del Norte Regional Strategic Health Framework pertained to
infectious disease surveillance or healthcare-associated infection transmission.
8.1 Healthy People 2020
Healthy People 2020 is a national strategic framework that provides science-based 10-year
objectives to improve the health of U.S. Citizens (U.S. Department of Health and Human Services,
2014; U.S.-Mexico Border Health Commission (BHC), ). The U.S. Department of Health and
Human Services releases a set of goals and objectives each decade to promote health measure
progress for health-related illnesses prevalent in specific populations.
The Healthy People 2020 topic area relevant to this thesis study is Healthcare-Associated
Infections, specifically the HAI-2 objective to “reduce invasive healthcare-associated methicillinresistant Staphylococcus aureus (MRSA) infections (U.S. Department of Health and Human
Services, 2014). The objective aims to reduce HA-MRSA infections from the baseline of 27.08
infections per 100,000 persons to 6.56 infections per 100,000 persons. HA-MRSA infections have
decreased thus far to 17.30 infections per 100,000 persons in 2014 (U.S. Department of Health and
Human Services, 2014). This thesis studied prevalence of S. aureus and MRSA colonization in
medical students who can potentially serve as vectors in transmitting the pathogen to patients.
Increasing awareness of colonization rates among students transitioning from medical school to
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the clinical setting may aid in reducing nosocomial MRSA infection in patients through screening
and decolonization methods.

8.2 City of El Paso Community Health Assessment
The City of El Paso Department of Public Health (DPH), in collaboration with the
Community Advisory Board (CAB), developed the Community Health Assessment and
Improvement Plan (CHA/CHIP) that outlines the health issues facing El Paso County residents
and aims to improve the health of the community (City of El Paso Department of Public Health,
2013). The Community Health Assessment contains a needs assessment of the health issues
prevalent to El Paso County and aims to influence community stakeholders to take action in
promoting health and reducing disease.
The priority area in the CHA/CHIP relevant to this thesis study is “Priority Area 6:
Surveillance and Communicable Disease Prevention” (City of El Paso Department of Public
Health, 2013). Objective 6.2 “target surveillance and communicable disease prevention and
interventions to geographic areas of highest need including colonias, select ZIP codes El Paso” is
closely related to this thesis study. The CHA/CHIP does not contain an objective specific to S.
aureus/MRSA, or reducing the transmission of infectious diseases in the healthcare setting.

8.3 CDC Framework for Preventing Infectious Diseases
The CDC’s Infectious Disease Framework was developed by multiple CDC organization
units including CDC’s Office of Infectious Diseases, Influenza Coordination Unit (ICU), and
infectious disease national centers (Centers for Disease Control and Prevention, 2011). The
framework aims to improve the CDC’s ability to prevent infectious diseases and stay up-to-date
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with rare, dangerous, and emerging infectious disease threats. The framework outlines three
elements that consist of strong public health fundamentals, high-impact interventions, and sound
health policies. Each element contains a set of priorities and activities to achieve each element.
The element relevant to this thesis study is “Element 1: Strengthen public health
fundamentals, including infectious disease surveillance, laboratory detection, and epidemiologic
investigation” (Centers for Disease Control and Prevention, 2011). The specific priority relevant
to this thesis is “Priority 1A: Modernize infectious disease surveillance to drive public health
action” (Centers for Disease Control and Prevention, 2011). Under Priority 1A, the CDC states
they are working with public health partners and the healthcare community to improve surveillance
of infectious diseases from the local level, to the federal level (Centers for Disease Control and
Prevention, 2011). Element 1 and Priority 1A closely relate to this thesis as this study was
conducted to gather data on colonization prevalence in future medical professionals.
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Chapter 9: MPH Core Competencies
The MPH program at UTEP has adapted, from the Association of Schools of Public Health
(ASPH), and developed specific core competencies that guide all courses, training, research, and
the practicum in the MPH program (University of Texas at El Paso College of Health Sciences
Department of Public Health Sciences, 2017). The core competencies adapted from the ASPHA
consist of: Biostatistics, Environmental Health Sciences, Epidemiology, Health Policy and
Management, and Social and Behavioral Sciences. The core competency developed specifically
for the MPH program at UTEP is the Hispanic and Border Health Concentration competency
(University of Texas at El Paso College of Health Sciences Department of Public Health Sciences,
2017). The core competencies relevant to this thesis study are Biostatistics, Epidemiology, and
Hispanic and Border Health Concentration.

9.1 Biostatistics
The Biostatistics core competency consists of “the development and application of
statistical reasoning and methods in addressing, analyzing, and solving problems in public health;
health care; and biomedical, clinical and population-based research” (University of Texas at El
Paso College of Health Sciences Department of Public Health Sciences, 2017). This thesis study
included the analysis of gathered data including medical history data.

9.2 Epidemiology
The Epidemiology core competency consist of studying disease and injury patterns in
communities and using the data to improve health problems (University of Texas at El Paso
College of Health Sciences Department of Public Health Sciences, 2017). This thesis study
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collected information and human specimens regarding a pathogen capable of causing lifethreatening illness. Over the course of the parent, four-year cohort study, the pattern of nasal
colonization of S. aureus or MRSA in healthcare professionals could provide insight as to the risk
it poses to infecting patients.
9.3 Hispanic and Border Health Concentration
The Hispanic and Border Health Concentration competency consists of “identifying the
major chronic, infectious, and other public health challenges that face Hispanic and border
communities” and “applying basic principles of prevention and control for chronic, infectious, and
other conditions especially those that differentially impact Hispanic and border communities”
(University of Texas at El Paso College of Health Sciences Department of Public Health Sciences,
2017). This thesis study was conducted to gather data useful to potentially decrease and prevent
pathogen transmission and reduce the amount of healthcare professionals that may serve as
reservoirs and vectors in the transmission of nosocomial infections.
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